Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Christopher Hunt Files Form 144 to Sell 19,000 IMXI Shares

Christopher Hunt, an officer of International Money Express, Inc., filed a Form 144 notice of proposed sale of 19,000 shares of common stock, with an approximate sale date of November 13, 2026, through Merrill Lynch.

Aakashdeep | 13 November 2026

Blankenship Files to Sell 4,000 INSW Shares via Rule 144

Director Alexandra Kate Blankenship filed a Form 144 notice of proposed sale with the SEC on November 13, 2026, covering 4,000 shares of International Seaways, Inc. common stock to be sold on the NYSE.

Nitish Kishor | 13 November 2026

Wise Group CFO Thomassin Files Form 144 for 6,040 Shares

Wise Group plc's Chief Financial Officer, Emmanuel Francois Jean-Claude Laurent Thomassin, filed a Form 144 notice of proposed sale of securities on November 13, 2026, covering 6,040 Class A ordinary shares acquired through a restricted stock unit vesting on October 15, 2026.

Aakashdeep | 13 November 2026

Daniel Leib Plans to Sell 50,000 DFIN Shares in Nov 2026

Donnelley Financial Solutions, Inc. officer Daniel Leib filed a Form 144 notice on November 13, 2026, disclosing a proposed sale of 50,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.

Anjali Anand | 13 November 2026

AdaptHealth Ex-CFO Clemens Files to Sell 10,000 Shares

Jason A. Clemens, former Chief Financial Officer of AdaptHealth Corp., filed a Form 144 notice on November 13, 2026, proposing the sale of 10,000 shares of AdaptHealth common stock through Morgan Stanley Smith Barney LLC.

Shwetambri Chauhan | 13 November 2026

Actuate Therapeutics Reports Q3 2026 Financials

Actuate Therapeutics, Inc. filed a quarterly report on Form 10-Q with the SEC covering the period ended September 30, 2026, disclosing a significant decline in cash and a shift to stockholders' deficit.

Manish Choudhary | 13 November 2026

Stemtech Posts $282K Q3 2026 Revenue, Deficit Widens

Stemtech Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting continued operating losses and a widening accumulated deficit for the direct-sales nutritional supplement company.

Aditi Sarkar | 13 November 2026

Dale B. Wolf Trust Plans to Sell 1,600 Molina Healthcare Shares

The Dale B. Wolf Revocable Trust, associated with a director of Molina Healthcare, Inc., filed a Form 144 notice on November 13, 2026, disclosing a proposed sale of 1,600 shares of Molina Healthcare common stock on the New York Stock Exchange.

Nitish Kishor | 13 November 2026

Digi Power X Discloses CEO-Linked Warehouse Lease in Alabama

Digi Power X Inc. filed Definitive Additional Materials on November 13, 2026, supplementing its proxy statement to disclose a related-party lease agreement with DOGE Capital, LLC, a company controlled by its CEO, effective July 1, 2026.

Anjali Anand | 13 November 2026

Dyadic International Q3 2026: Going-Concern Doubt Disclosed

Dyadic International, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, disclosing a going-concern warning and a shift to a stockholders' deficit position.

Aditi Sarkar | 13 November 2026
Support

Hi! How can we help you today?

Loading…